ESMO 2020 Highlights on durability of clinical benefit and biomarkers with AMG510 in NSCLC

• Date : 19/09/2020
• 2    
  0

ESMO 2020 Highlights on nivolumab+cabozantinib as 1st line therapy for aRCC: The CheckMate 9ER study

• Date : 19/09/2020
• 2    
  0

OncLive News Network On Location: ESMO 2020 Day 1

• Date : 19/09/2020
• 2    
  0

OncLive News Network On Location: ESMO 2020 Day 3

• Date : 19/09/2020
• 2    
  0

ESMO 2020 Highlights on blocking PI3K/AKT signalling pathway in mCRPC: The IPATential150 study

• Date : 19/09/2020
• 1    
  0

ESMO 2020 Highlights on lenvatinib plus pembrolizumab in advanced solid tumours: LEAP-005

• Date : 19/09/2020
• 1    
  0

ESMO 2020 Highlights on 1st line durvalumab and tremelimumab for mPDAC: The PA.7 study

• Date : 19/09/2020
• 1    
  0

ESMO 2020 Highlights on neoadjuvant ICI in early TNBC: The IMpassion031 study

• Date : 19/09/2020
• 1    
  0

ESMO 2020 Highlights on adjuvant osimertinib for EGFR mutated NSCLC: The ADAURA study

• Date : 19/09/2020
• 1    
  0

ESMO 2020 Highlights on 1st line lorlatinib for ALK+ NSCLC: The CROWN Study

• Date : 19/09/2020
• 1    
  0

ESMO 2020 Satellite Symposium: Philip Jermann - NTRK, RET and other fusion biomarkers testing

• Date : 15/09/2020
• 1    
  0

ESMO Congress 2020 Public Policy Sessions

• Date : 19/09/2020
• 1    
  0

ESMO 2020 Gabriela Fernandes talk: Lung cancer diagnostic test needs: perspective from a thoracic

• Date : 15/09/2020
• 1    
  0

ESMO 2020 Highlights on pembrolizumab as 1st line therapy for aUC: The KEYNOTE-361 study

• Date : 19/09/2020
• 1    
  0

ESMO 2020 Highlights on neoadjuvant mFOLFIRINOX for T3-4 rectal cancer: The PRODIGE 23 study

• Date : 19/09/2020
• 1    
  0

ESMO Virtual Meeting 2020: anticipations on promising studies in lung cancer

• Date : 19/09/2020
• 1    
  0

ESMO Virtual Congress 2020

• Date : 19/09/2020
• 1    
  0

ESMO W4O Roundtable: Has the COVID-19 pandemic exacerbated gender inequalities?

• Date : 19/09/2020
• 0    
  0

ESMO 2020 Satellite Symposium Philip Jermann talk: Genomic profiling is driving the precision

• Date : 15/09/2020
• 0    
  0

ESMO 2020 Highlights on alpelisib plus fulvestrant for HR+/HER2– ABC: The SOLAR-1 study

• Date : 19/09/2020
• 0    
  0

ESMO 2020 Highlights on sacituzumab govitecan in metastatic TNBC: The ASCENT study

• Date : 19/09/2020
• 0    
  0

ESMO 2020 Highlights on pembrolizumab in LA-HNSCC: The GORTEC 2015-01 “PembroRad” study

• Date : 19/09/2020
• 0    
  0

ESMO Virtual Congress 2020: Welcoming the oncology community

• Date : 19/09/2020
• 0    
  0

ESMO Virtual Congress 2020: anticipations on practice-changing results in gastric cancers

• Date : 19/09/2020
• 0    
  0

John Haanen on new data presented at ESMO Virtual Congress 2020

• Date : 19/09/2020
• 0    
  0

John Haanen tells you why you can't miss ESMO Virtual Congress 2020

• Date : 19/09/2020
• 0    
  0

John Haanen on COVID-19 and cancer research?

• Date : 19/09/2020
• 0    
  0

John Haanen on how ESMO Virtual Congress 2020 will be different?

• Date : 19/09/2020
• 0    
  0

ESMO Vision 2020: Integrated Cancer Care

• Date : 19/09/2020
• 0    
  0

ESMO Academy 2020 Virtual Meeting: Welcome to the ESMO Booth!

• Date : 19/09/2020
• 0    
  0

OncLive News Network On Location ESMO 2020 Day 2

• Date : 19/09/2020
• 0    
  0

1res Journées de la Breast Academy - SFSPM 2021

• Date : 12/11/2021
• 200    
  0

43es Journées de la Société Française de Sénologie et de Pathologie Mammaire - SFSPM 2021

• Date : 10/11/2021
• 205    
  0

11e Congrès National des réseaux en Cancérologie (CNRC 2021)

• Date : 23/09/2021
• 772    
  0

World Conference on Lung Cancer - IASLC 2021

• Date : 26/01/2021
• 608    
  0

san antonio breast cancer symposium SABCS 2020

• Date : 08/12/2020
• 2833    
  0